An Impeccable Audience Quality to Ensure Meaningful Precision Medicine Connections

Just Confirmed to Attend

  • Alexion Pharmaceuticals
  • Vertex Pharmaceuticals
  • GSK
  • American Cancer Society
  • Low Institute for Therapeutics
  • Genmab
  • Remix Therapeutics
  • Amgen

Teams Attending

  • Acrivon Therapeutics 8
  • AstraZeneca 22
  • Bristol Myers Squibb 27
  • Johnson & Johnson Innovative Medicines 26
  • Lahey Clinic 8
  • Merck 31
  • Novartis 14
  • Takeda 24

Senior Decision-Makers Joining Daily

  • Associate Director, Translational Clinical Research
  • Associate Director, Precision Medicine
  • Associate Vice President, Clinical Laboratory Sciences Oncology
  • Co-Director
  • Head, Exploratory Biomarker
  • Head, Precision Medicine
  • Senior Director, DMPK
  • Vice President & Head, Translational Sciences

Real-Time Industry Participation Trends

Biopharma leaders have already confirmed from 125+ drug developer organizations

83% of the total pharma landscape are confirmed to attend next month's landmark meeting

Brand-new companies attending include Adicet Bio, Alentis Therapeutics, ReST Therapeutics, NW PharmaTech and Ultragenyx

A highly targeted audience, with 71% of current 2026 attendees at Director/Head level or above

60+ industry-leading biopharma companies are sending multiple precision medicine team members

65+ industry-leading service and solution providers are already partnered with this meeting

Audience Breakdown

Take a sneak preview at the 850+ senior stakeholders joining us for the 16th World Clinical Biomarkers & Companion Diagnostics Summit.

Company Types
Types of Companies Attending
Seniority
Seniority of Attendees
Expertise & Job Titles
CDx Word Cloud (2)

*Statistics Taken from 15th World Clinical Biomarkers & Companion Diagnostics Summit

See the Full Event Line-Up
2
Explore the New Agenda

Hear the latest imaging, multi-omics, single-cell and functional assays, enhanced by AI-driven digital biomarker strategies, enabling earlier and smarter treatment decisions for oncology, autoimmune, neurological, chronic and rare disease patients

View the Presentation & Speaker Line-Up
CDx Europe - Networking Page
Partner with Us

Position your solutions alongside leading biomarker, diagnostic and technology providers, to ensure your brand is front and center, and retain your place as the partner of choice in the ever-expanding precision medicine space

View Partnership Options
1
Join 850+ Specialist Experts

Be part of the liveliest Rx-Dx conversations with like-minded industry peers spanning a range of precision therapy modalities, and build high-value connections during dedicated networking sessions designed to foster collaborations

Register Now